Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...
Senate hearing for Casey Means, Trump’s surgeon general pick, is postponed after she goes into labor
A Thursday Senate hearing for President Trump's surgeon general pick, Casey Means, has been postponed because she went into ...
The stock market pummeled Cigna after the company revealed its new plan to ditch pharmacy benefit rebates will lower that ...
A bidding war between Novo Nordisk and Pfizer has broken into the open for Metsera, which focuses on developing drugs to ...
It’s no secret that our bodies’ ability to ward off pathogens and mount strong vaccine responses weakens with age, but ...
“Into 2026, we expect only modest sequential improvement,” wrote Evercore ISI’s Elizabeth Anderson, adding: “Management ...
Has BridgeBio's business model worked? How are executives at Moderna dealing with the company's slump? Find out on the new episode of "The Readout LOUD." ...
In September, the Food and Drug Administration released its recent complete response letter (CRL) to Lykos Therapeutics, ...
The Trump administration has dismantled big chunks of the federal agency focused on mental health and addiction treatment, ...
Moderna’s market value has fallen by more than 90% — $185 billion, or a full Sony — from its 2021 peak to around $10 billion ...
A bidding war has broken into the open for the obesity-focused Metsera, with Novo Nordisk aiming to outbid Pfizer for the ...
WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback